Bioanalytical method development & validation | Labcorp Drug Development Catalog

Evaluation

Bioanalysis, LC-MS, IChem

Sponsors and investigators need to prepare for quantitative analysis of targeted analytes and metabolites as part of drug investigations. Bioanalytical method development is a key component of a diverse array of processes, including human clinical trials and research model studies.

After successful analytical method development, you'll need to receive formal validation from regulatory authorities to ensure that the method's accuracy, specificity, robustness, reproducibility and other properties are compliant with regulatory guidelines.

Our analytical method validation services can help ensure regulatory compliance and clear communication between sponsors, investigators and authorities. Learn more about our bioanalytical services.

Molecule or Product Type

Biologics, Small Molecule, Vaccine

Models

Canine, Human, Mini-pig, Mouse, NHP, Other Model, Rabbit, Rat

Regulatory

FIH, IND & CTA, Post-Market

Industry Market

Pharma

Phase

Clinical, Discovery, Nonclinical

Request a Quote

About our nonclinical animal research models: We provide the utmost care for our research animals and actively pursue advances in animal welfare. As well as ensuring the highest scientific, ethical and regulatory standards, selection of appropriate animal research models for development research is critical to developing safe and effective treatments, devices and products that protect and save lives. Just as we have ethical committee oversight for human trials, we have ethical committees overseeing all aspects of our global animal care and use programs. All of our core, nonclinical facilities are accredited by AAALAC. Learn more about our commitment to replacing, reusing and refining nonclinical research models.